Yi Liu
Nektar Therapeutics (United States) · 54 works · 383 citations · h-index 10
Top works
- Principal stratum strategy: Potential role in drug development
- Sample size and power for the weighted log‐rank test and Kaplan‐Meier based tests with allowance for nonproportional hazards
- Testing for Efficacy in Primary and Secondary Endpoints by Partitioning Decision Paths
- Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials—Application of the Estimand Framework
- Partition testing in dose–response studies with multiple endpoints
- The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trials
- Pseudo maximum likelihood estimation for the Cox model with doubly truncated data
- Correct and logical causal inference for binary and time‐to‐event outcomes in randomized controlled trials
- A flexible joint model for multiple longitudinal biomarkers and a time‐to‐event outcome: With applications to dynamic prediction using highly correlated biomarkers
- ABC Variable Selection with Bayesian Forests
- A new joint screening method for right-censored time-to-event data with ultra-high dimensional covariates
- Innovations in Clinical Development in Rare Diseases of Children and Adults: Small Populations and/or Small Patients
- Pseudo MLE for semiparametric transformation model with doubly truncated data
- Sample size re-estimation for pivotal clinical trials
- From Logic-Respecting Efficacy Estimands to Logic-Ensuring Analysis Principle for Time-to-Event Endpoint in Randomized Clinical Trials with Subgroups
- Testing multiple primary endpoints in clinical trials with sample size adaptation
- Model-free feature screening for ultra-high dimensional competing risks data
- Research on Prediction of Traffic Flow at Non-detector Intersections Based on Ridge Trace and Fuzzy Linear Regression Analysis
- Thresholding of a Continuous Companion Diagnostic Test Confident of Efficacy in Targeted Population
- Preclinical Assessment of the Analgesic Pharmacology of NKTR-181 in Rodents